Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06BA Centrally acting sympathomimetics
N06BA12 Lisdexamfetamine
D04747 Lisdexamfetamine dimesylate (USAN) <JP/US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Attention Deficit Hyperactivity Disorder Agents, Amphetamines
Lisdexamfetamine
D04747 Lisdexamfetamine dimesylate (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
117 Psychotropics
1179 Others
D04747 Lisdexamfetamine dimesylate (USAN); Lisdexamfetamine mesilate (JAN)
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D04747 Lisdexamfetamine dimesylate (USAN) <JP/US>
SLC6A3 (DAT1)
D04747 Lisdexamfetamine dimesylate (USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D04747
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D04747
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D04747
Prodrugs [br08324.html]
DG00973